Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhangjiagang CIMC Sanctum Cryogenic Equipment Co., Ltd. (CIMC Sanctum) is a prominent manufacturer of cryogenic storage and transportation equipment, serving as a core subsidiary of CIMC Enric. The company provides critical infrastructure for the healthcare and life sciences industries, including medical oxygen storage systems for hospitals and advanced liquid nitrogen biological containers for bio-banking. Its products are essential for the long-term preservation of vaccines, stem cells, and other temperature-sensitive biological samples, supporting the global biomedical cold chain. CIMC Sanctum integrates sophisticated technologies such as high-vacuum multilayer insulation and intelligent monitoring systems to ensure product reliability and safety. Recognized as a "National Torch Plan" high-tech enterprise, the company maintains extensive R&D collaborations with leading academic institutions to drive innovation in cryogenic engineering. During the COVID-19 pandemic, the company was a key supplier of liquid oxygen tanks to hospitals, demonstrating its vital role in emergency medical response.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CIMC Sanctum.